Literature DB >> 21703593

Clinicopathologic predictors for early and late biochemical hypothyroidism after hemithyroidectomy.

Kevin Ka-Wan Chu1, Brian Hung-Hin Lang.   

Abstract

BACKGROUND: Biochemical hypothyroidism (BH) after hemithyroidectomy is an under-recognized complication with a reported incidence of 9% to 43%. This study aimed to identify potential clinicopathologic risk factors associated with early (<12 months after hemithyroidectomy) and late-onset (≥12 months after hemithyroidectomy) BH.
METHODS: From 2005 to 2008 there were 263 postsurgical patients who were eligible for analysis. Serum thyroid stimulating hormone (TSH) level was checked regularly after surgery. Postoperative TSH reaching a level higher than 5.5 mIU/L was defined as BH. The overall median follow-up period was 21 months (range, 3-62 mo). Any clinicopathologic factors significantly associated with BH in the univariate analysis were entered into multivariate analysis. A further analysis was performed comparing factors between early and late-onset BH.
RESULTS: There were 38 patients who developed subsequent BH, 33 of these cases developed within 2 years. Those patients with BH were significantly older (P = .037), had a higher preoperative TSH level (P < .001), longer follow-up period (P < .001), more frequent thyroiditis on histology (P = .043), lighter resected tissue weight (P = .001), and were more likely to have positive antimicrosomal antibodies (P = .043) than those without BH. However, in the multivariate analysis after adjusting for different follow-up periods in the 2 groups, only lighter resected tissue weight (P = .036) and concomitant thyroiditis on histology (P = .005) turned out to be independent factors for BH. Thyroiditis on histology was also the only significant risk factor for developing early onset BH.
CONCLUSIONS: Patients with lighter resected tissue weight and concomitant thyroiditis on histology were particularly at risk for subsequent BH. Although not all patients with thyroiditis developed BH, in those who did develop BH it occurred within the first 11 months.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703593     DOI: 10.1016/j.amjsurg.2011.03.004

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

Review 1.  Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers.

Authors:  Timothy M Ullmann; Katherine D Gray; Maureen D Moore; Rasa Zarnegar; Thomas J Fahey
Journal:  Gland Surg       Date:  2018-10

Review 2.  Managing newly diagnosed thyroid cancer.

Authors:  Anna M Sawka; James D Brierley; Shereen Ezzat; David P Goldstein
Journal:  CMAJ       Date:  2013-10-07       Impact factor: 8.262

3.  Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma.

Authors:  Song Jae Lee; Chang Myeon Song; Yong Bae Ji; Yun Young Choi; Young Seok Sohn; Jung Hwan Park; Dong Sun Kim; Kyung Tae
Journal:  Langenbecks Arch Surg       Date:  2021-05-10       Impact factor: 3.445

4.  Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

Authors:  Zhe Li; Yuxuan Qiu; Yuan Fei; Zhichao Xing; Jingqiang Zhu; Anping Su
Journal:  Endocrine       Date:  2020-07-07       Impact factor: 3.633

5.  Hypothyroidism after hemithyroidectomy.

Authors:  Meena Said; Vicki Chiu; Philip I Haigh
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

6.  Risk Factors that Predict Levothyroxine Medication after Thyroid Lobectomy.

Authors:  H S Song; C J Kim; S Lee; J S Bae; C K Jung; J Jang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

7.  Risk Factors of Post-Hemithyroidectomy Hypothyroidism.

Authors:  Alhanoof K Al-Shalhoub; Saleh Al-Dhahri
Journal:  Saudi J Med Med Sci       Date:  2016-11-16

8.  Prospective analysis of risk for hypothyroidism after hemithyroidectomy.

Authors:  Virgilijus Beisa; Darius Kazanavicius; Arminas Skrebunas; Gintaras Simutis; Justinas Ivaska; Kestutis Strupas
Journal:  Int J Endocrinol       Date:  2015-03-30       Impact factor: 3.257

9.  The Effect of Levothyroxine Discontinuation Timing on Postoperative Hypothyroidism after Hemithyroidectomy for Papillary Thyroid Microcarcinoma.

Authors:  Tae Kwun Ha; Dong Wook Kim; Ha Kyoung Park; Jin Wook Baek; Yoo Jin Lee; Young Mi Park; Do Hun Kim; Soo Jin Jung; Ki Jung Ahn
Journal:  Int J Endocrinol       Date:  2016-05-11       Impact factor: 3.257

10.  Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up.

Authors:  Soo Young Kim; Hee Jun Kim; Seok-Mo Kim; Hojin Chang; Yong Sang Lee; Hang-Seok Chang; Cheong Soo Park
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.